Literature DB >> 7561229

Differential effects of hypnotic suggestion on multiple dimensions of pain.

L A Dahlgren1, R M Kurtz, M J Strube, M D Malone.   

Abstract

Within the framework of multidimensional pain assessment, this study extended an earlier finding that hypnotic analgesia and relaxation suggestions have differential effects on pain reduction by evaluating these strategies in subjects undergoing a cold pressor protocol. Thirty-two highly susceptible subjects were randomly assigned to an analgesia or a relaxation suggestion treatment group. Six pain reports were taken at 10-sec intervals for each experimental condition. The baseline measures served as covariates. A 2 x 2 x 2 x 6 repeated-measures analysis of covariance (ANCOVA) revealed a significant group (analgesia, relaxation) by pain dimension (intensity, unpleasantness), by condition (suggestion alone, hypnotic induction plus suggestion) interaction. Analysis of the simple-simple main effects, holding both group and condition constant, revealed that application of hypnotic analgesia reduced report of pain intensity significantly more than report of pain unpleasantness. Conversely, hypnotic relaxation reduced pain unpleasantness more than intensity. The clinical implications of the study are discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7561229     DOI: 10.1016/0885-3924(95)00055-4

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  2 in total

1.  The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience? A systematic review.

Authors:  K Talbot; V J Madden; S L Jones; G L Moseley
Journal:  Br J Anaesth       Date:  2019-05-01       Impact factor: 9.166

2.  Hypnotic relaxation results in elevated thresholds of sensory detection but not of pain detection.

Authors:  Sybille Kramer; Rolf Zims; Michael Simang; Linda Rüger; Dominik Irnich
Journal:  BMC Complement Altern Med       Date:  2014-12-15       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.